What does Preamble of Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026. do?

This bill proposes to amend title XVIII of the Social Security Act. The proposed amendment concerns prescription drug plans (PDPs) under Medicare Part D. It would require PDP sponsors who use a formulary to include certain generic drugs and biosimilar biological products on that formulary.

What does SHORT TITLE. of Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026. do?

This bill is formally titled the Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.

What does REQUIREMENTS FOR PDP SPONSORS OF PRESCRIPTION DRUG PLANS UNDER of Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026. do?

This section amends Section 1860D-4(b)(3) of the Social Security Act. Beginning January 1, 2027, prescription drug plan (PDP) formularies must include covered generic drugs in a preferred position if their wholesale acquisition cost is less than the reference drug. PDP formularies must also include at least two covered biosimilar biological products in a preferred position if their wholesale acquisition cost is less than the reference biological product. PDP sponsors cannot impose more restrictive access limits on covered generic drugs or biosimilar biological products than those imposed on the reference drugs. The section defines key terms including 'covered biosimilar biological product,' 'covered generic drug,' 'preferred position,' 'reference biological product,' 'reference drug,' and 'wholesale acquisition cost'.

Back to bills

Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.

Last updated: 3/27/2026 · Introduced: 3/27/2026

Author: Doris Matsui (D-CA)

TL;DR (AI)

Starting in 2027, Medicare Part D prescription drug plans must place lower-cost generic drugs in a preferred position on their formularies.
Medicare Part D prescription drug plans must include at least two preferred biosimilar biological products if their cost is lower than the reference product.
Prescription drug plans cannot restrict access to covered generic drugs or biosimilar biological products more than they restrict access to the reference drugs.

119th Congressin committeeOfficial page

Verified Votes

No verified votes yet.

Community Votes

No community votes yet. Be the first!

Voting as guest · Sign in for verified votes

Other Sections

Includes provisions on preamble, short title., and 1 more.

3 sections

Click "Show details" to explore individual sections. Use the community vote above or visit All Sections to vote per section.

Read official text

Want the full experience?

Create a free account to cast verified votes on each section, get a personalized summary, and track your voting history.

Create Free Account